Harbour Capital Advisors, LLC Edwards Lifesciences Corp Transaction History

Harbour Capital Advisors, LLC

$415 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$84.3 - $94.31 $26,554 - $29,707	-315 Reduced 3.05%	10,003 $923,000
Q1 2024 Apr 16, 2024	SELL	$72.54 - $95.56 $5,440 - $7,167	-75 Reduced 0.72%	10,318 $985,000
Q4 2023 Jan 05, 2024	SELL	$61.71 - $77.76 $79,112 - $99,688	-1,282 Reduced 10.98%	10,393 $792,000
Q3 2023 Oct 05, 2023	SELL	$69.28 - $93.38 $432,722 - $583,251	-6,246 Reduced 34.85%	11,675 $808,000
Q2 2023 Jul 10, 2023	SELL	$81.41 - $94.33 $44,938 - $52,070	-552 Reduced 2.99%	17,921 $1.69 Million
Q1 2023 Apr 19, 2023	SELL	$74.26 - $84.51 $711,262 - $809,436	-9,578 Reduced 34.14%	18,473 $1.53 Million
Q4 2022 Jan 13, 2023	SELL	$68.3 - $87.44 $562,450 - $720,068	-8,235 Reduced 22.69%	28,051 $0
Q3 2022 Oct 19, 2022	SELL	$82.37 - $107.29 $6,589 - $8,583	-80 Reduced 0.22%	36,286 $3 Million
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $3,027 - $4,489	-35 Reduced 0.1%	36,366 $3.46 Million
Q1 2022 Apr 11, 2022	BUY	$101.96 - $128.34 $31,709 - $39,913	311 Added 0.86%	36,401 $4.29 Million
Q4 2021 Jan 12, 2022	BUY	$106.37 - $130.68 $19,146 - $23,522	180 Added 0.5%	36,090 $4.68 Million
Q3 2021 Oct 13, 2021	BUY	$102.91 - $122.75 $68,023 - $81,137	661 Added 1.88%	35,910 $4.07 Million
Q2 2021 Jul 14, 2021	SELL	$83.84 - $104.76 $19,702 - $24,618	-235 Reduced 0.66%	35,249 $3.65 Million
Q1 2021 Apr 12, 2021	BUY	$78.68 - $90.67 $74,352 - $85,683	945 Added 2.74%	35,484 $2.97 Million
Q4 2020 Jan 12, 2021	BUY	$71.69 - $91.23 $52,333 - $66,597	730 Added 2.16%	34,539 $3,000
Q3 2020 Oct 09, 2020	BUY	$67.19 - $87.44 $9,809 - $12,766	146 Added 0.43%	33,809 $2.7 Million
Q2 2020 Jul 21, 2020	BUY	$57.54 - $76.95 $1.29 Million - $1.73 Million	22,439 Added 199.92%	33,663 $2.33 Million
Q1 2020 Apr 08, 2020	BUY	$52.41 - $81.0 $11,163 - $17,253	213 Added 1.93%	11,224 $2.12 Million
Q4 2019 Jan 22, 2020	BUY	$71.7 - $82.09 $7,600 - $8,701	106 Added 0.97%	11,011 $2.57 Million
Q3 2019 Oct 30, 2019	SELL	$61.55 - $75.43 $11,079 - $13,577	-180 Reduced 1.62%	10,905 $2.4 Million
Q2 2019 Jul 10, 2019	BUY	$55.74 - $64.41 $5,462 - $6,312	98 Added 0.89%	11,085 $2.05 Million
Q1 2019 Apr 24, 2019	SELL	$47.89 - $64.05 $29,404 - $39,326	-614 Reduced 5.29%	10,987 $2.1 Million
Q4 2018 Jan 23, 2019	BUY	$46.41 - $56.94 $15,222 - $18,676	328 Added 2.91%	11,601 $1.78 Million
Q3 2018 Nov 07, 2018	SELL	$45.7 - $58.03 $685 - $870	-15 Reduced 0.13%	11,273 $1.96 Million
Q2 2018 Jul 11, 2018	SELL	$42.45 - $51.3 $1,485 - $1,795	-35 Reduced 0.31%	11,288 $1.65 Million
Q1 2018 Apr 18, 2018	BUY	$37.19 - $47.45 $11,752 - $14,994	316 Added 2.87%	11,323 $1.58 Million
Q4 2017 Jan 24, 2018	BUY	$33.79 - $39.39 $53,895 - $62,827	1,595 Added 16.95%	11,007 $1.24 Million
Q3 2017 Nov 08, 2017	BUY	$36.29 - $38.83 $341,561 - $365,467	9,412	9,412 $1.03 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.

Account